Human Papillomavirus Vaccination Status and Related Factors among Some Female College Students

일부 여대생에서 인유두종 바이러스 예방접종과 관련요인

  • Bang, Seunghyun (Department of Medicine, College of Medicine, Chosun University) ;
  • Yoo, Aeri (Department of Medicine, College of Medicine, Chosun University) ;
  • Cho, Sunyoung (Department of Medicine, College of Medicine, Chosun University) ;
  • Choi, Insun (Department of Medicine, College of Medicine, Chosun University) ;
  • Kim, Sungwan (Department of Medicine, College of Medicine, Chosun University) ;
  • Jeong, Yoo (Department of Medicine, College of Medicine, Chosun University) ;
  • Lee, Eunhye (Department of Medicine, College of Medicine, Chosun University) ;
  • Jang, Chuntae (Department of Medicine, College of Medicine, Chosun University) ;
  • Han, Mi Ah (Department of Preventive Medicine, College of Medicine, Chosun University)
  • 방승현 (조선대학교 의학전문대학원) ;
  • 유애리 (조선대학교 의학전문대학원) ;
  • 조선영 (조선대학교 의학전문대학원) ;
  • 최인선 (조선대학교 의학전문대학원) ;
  • 김성완 (조선대학교 의학전문대학원) ;
  • 정유 (조선대학교 의학전문대학원) ;
  • 이은혜 (조선대학교 의학전문대학원) ;
  • 장춘태 (조선대학교 의학전문대학원) ;
  • 한미아 (조선대학교 의학전문대학원 예방의학교실)
  • Published : 2012.07.31

Abstract

Objectives: The purpose of this study was to investigate the vaccination status of female university students for the human papillomavirus (HPV) vaccine for cervical cancer prevention, as well as factors associated with vaccination. Methods: 348 female university students were selected using convenience sampling methods. Demographic characteristics, health-related behavior, and cervical cancer-related knowledge were collected by self-reported questionnaire on 9~10 November 2011. Vaccinated subjects were defined as those who received at least one of the three doses in the HPV vaccine series. The differences in vaccination status were tested with chi-square test, t-test and multiple logistic regression analysis. Results: Of 348 female students, 39 (11.2%) reported that they were vaccinated. In simple analysis, age, major, allowance, parental academic background, obstetrics and gynecology visiting experience and knowledge about HPV vaccination were associated with being vaccinated. In multiple logistic regression, having a high allowance (OR=3.97, 95% CI=1.37~11.53), having parents with a high academic background (OR=3.14, 95% CI=1.13~8.68) and having more knowledge about HPV vaccination (OR=2.27, 95% CI=1.15~4.48) were significantly associated with being vaccinated. Conclusions: Allowance, parental academic background and knowledge about HPV vaccination were associated with vaccination status. Considering these factors will help in decision-making regarding HPV vaccination. Future study is needed to include other populations involved in making decisions about HPV vaccination, including adolescents and their parents.

Keywords

References

  1. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of human papillomavirus infection: provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccine. Pediatrics 2007;120(3):666-8 https://doi.org/10.1542/peds.2007-1735
  2. Bang KS, Sung S, Koo B, Kim M, Kim Y, Kim J, Ryu S. Female university students' HPV-related knowledge and influencing factors on HPV vaccination. Jounal of Korean Oncology Nursing 2011;11(3):186-192 https://doi.org/10.5388/jkon.2011.11.3.186
  3. Baseman JG & Kousky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005;32 Suppl 1: S16-24
  4. Baykal C, Al A, Ugur MG, Cetinkaya N, Attar R, et al. Knowledge and interest of Turkish women about cervical cancer and HPV vaccine. Eur J Gynaecol Oncol 2008;29(1):76-9
  5. Bekkers RL, Massuger LF, Bulten J, Melchers WJ. Epidemiological and clinical aspects of human papillomavirus defection in the prevention of cervical cancer. Rev Med Virol 2004;14:95-105 https://doi.org/10.1002/rmv.416
  6. Bosch FX, Manos MM, Mun oz N, Sherman M, Jansen AM, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87(11):796-802 https://doi.org/10.1093/jnci/87.11.796
  7. Brown DR, Shew ML, Qudadri B, Neptune N, Vargas M, et al. A longitudinal study of genital human papillomavirus infection in cohort of closely followed adolescent women. J Infect Dis 2005;191:182-92 https://doi.org/10.1086/426867
  8. Choi KA, Oh JK, Shin HR, Kim JH, Lee KS et al. Knowledge of human papillomavirus infection and acceptability of vaccination among adult women in Korea. Korean J Obstet Gynecol 2008;51(6):617-623
  9. Daley EM, Vamos CA, Buhi ER, Kolar SK, McDermott RJ, et al. Influences on human papillomavirus vaccination status among female college students. J Womens Health (Larchmt) 2010;19(10):1885-91 https://doi.org/10.1089/jwh.2009.1861
  10. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, et al. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect 2009;85(7):499-502 https://doi.org/10.1136/sti.2009.037788
  11. Joo WD, Kim SH, Kim DY, Suh DS, Kim JH, et al. Prevalence of human papillomavirus infection in Korean women: risks of abnormal Pap smear and cervical neoplasia. Korean J Gynecol Oncol Colposc 2004;15(4):309-316
  12. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011;43(1):1-11 https://doi.org/10.4143/crt.2011.43.1.1
  13. Kang HS & Moneyham L. Attitudes toward and intention to receive the human papilloma virus (HPV) vaccination and intention to use condoms among female Korean college students. Vaccine 2010;28(3):811-6 https://doi.org/10.1016/j.vaccine.2009.10.052
  14. Kim CH, Park TC, Park JS. Recent Clinical Review : Efficacy of human papillomavirus vaccines including cross protection: A review of recent evidence. Korean J Obstet Gynecol 2010; 53(2):103-118 https://doi.org/10.5468/kjog.2010.53.2.103
  15. Kivistik A, Lang K, Baili P, Anttila A, Veerus P. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia. BMC Womens Health 2011;11:43 https://doi.org/10.1186/1472-6874-11-43
  16. Lee EJ. Levels of knowledge about cervical cancer, health beliefs and human papillomavirus vaccination rate in female university students[dissertation]. Keimyung University; 2010.
  17. Lee EJ, Park JS. Knowledge about cervical cancer, health beliefs and human papillomavirus vaccination rate in female university students. J Korean Oncol Nurs 2011;11(1):65-73 https://doi.org/10.5388/jkon.2011.11.1.65
  18. Licht AS, Murphy JM, Hyland AJ, Fix BV, Hawk LW, et al. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sex Transm Infect. 2010;86(1):74-8. https://doi.org/10.1136/sti.2009.037705
  19. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79(3):328-337 https://doi.org/10.1097/00006250-199203000-00002
  20. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-2):1-24.
  21. Oh JK, Lim MK, Yun EH, Lee EH, Shin HR. Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea:a nationwide interview survey. Vaccine 2010;28(7):1854-60 https://doi.org/10.1016/j.vaccine.2009.11.079
  22. Rama CH, Villa LL, Pagliusi S, Andreoli MA, Costa MC, et al. Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in Sao Paulo, Brazil--a crosssectional study. BMC Womens Health 2010;10:35 https://doi.org/10.1186/1472-6874-10-35
  23. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health 2007;7:304 https://doi.org/10.1186/1471-2458-7-304
  24. Syrjänen KJ. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). Eur J Obstet Gynecol Reprod Biol 1996;65(1):45-53 https://doi.org/10.1016/0028-2243(95)02303-A
  25. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12-9 https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  26. Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000;27:49-52 https://doi.org/10.1097/00007435-200001000-00010
  27. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92(9):690-8 https://doi.org/10.1093/jnci/92.9.690